PedAM
Pediatric Disease Annotations & Medicines
| Disease | colorectal cancer |
| Phenotype | C0494165|hepatic metastases |
| Sentences | 26 |
| PubMedID- 23802071 | A similar cell subset was identified in patients bearing hepatic metastases of colorectal cancer, highlighting the potential therapeutic relevance of our findings. |
| PubMedID- 21980591 | [2] on 309 patients with hepatic metastases of colorectal cancers, survival rates were significantly increased after rfa in cases where the number of tumors was ≤ 5, their maximal diameters were ≤ 5 cm, and there were no metastases besides the liver. |
| PubMedID- 22216763 | Methods: blood samples were prospectively and consecutively taken from 49 colorectal cancer patients with extensive hepatic metastases before, three, six, 24 and 48 h after sirt to analyze the concentrations of nucleosomes and further laboratory parameters, and to compare them with the response to therapy regularly determined 3 months after therapy and with overall survival. |
| PubMedID- 26388907 | We investigated the factors that predicted survival following surgical resection of hepatic metastases in patients with colorectal cancer. |
| PubMedID- 25706878 | Our results suggest that the diagnostic performance for small hepatic metastases in patients with colorectal cancer, especially for lesions less than 1 cm in size, can be improved by combined review of ct images and aef color mapping. |
| PubMedID- 20683670 | Purpose: the purpose of this study was to determine the most useful parameter of dual-time-point 2-deoxy-2-[(1)(8)f]fluoro-d: -glucose positron emission tomography/computed tomography (pet/ct) for detection of hepatic metastases in patients with colorectal cancer. |
| PubMedID- 23715781 | Treatment sequence for colorectal cancer with hepatic metastases. |
| PubMedID- 25625240 | Cd44 and cd133 mrna were highly correlatively co-expressed in colorectal cancer with hepatic metastases. |
| PubMedID- 20598004 | Sirt results in measurable tumour responses or delayed disease progression in the majority of eligible patients with hepatocellular carcinoma or hepatic metastases arising from colorectal cancer. |
| PubMedID- 22412969 | As controls, liver tissues were obtained from patients undergoing partial liver resection for hepatic metastases of colorectal cancer. |
| PubMedID- 25129331 | colorectal cancer with potentially resectable hepatic metastases: optimizing treatment. |
| PubMedID- 24941686 | The combination of hepatic intraarterial chemotherapy and systemic chemotherapy can increase the probability of curing colorectal cancer with hepatic metastases not immediately accessible to surgical treatment or percutaneous ablation. |
| PubMedID- 23648304 | Objective: to analyze the outcomes of simultaneous liver resection for patients who have primary colorectal cancer with synchronous hepatic metastases to see if there is any advantage for doing so. |
| PubMedID- 26085905 | Liver-first approach of colorectal cancer with synchronous hepatic metastases: a reverse strategy. |
| PubMedID- 22235376 | Sir-spheres come with premarket approval (pma) for unresectable hepatic metastases of colorectal cancer in the united states and may be utilized “off-label” for other tumors without prejudice under the using physicians discretion authority and responsibility. |
| PubMedID- 20872814 | Background: surgical indication for stage iv colorectal cancer patients with bilobar hepatic metastases may be controversial. |
| PubMedID- 25083712 | Samples were resected upon surgical treatment of hepatic metastases in colorectal cancer. |
| PubMedID- 24457263 | Limitations of body surface area-based activity calculation for radioembolization of hepatic metastases in colorectal cancer. |
| PubMedID- 23715907 | The liver-first approach to the management of colorectal cancer with synchronous hepatic metastases: a systematic review. |
| PubMedID- 25922690 | Had reported currently that there was no significant difference in overall survival between patients presenting with stable disease (sd) and patients presenting with partial response (pr) after radioembolization for hepatic metastases of colorectal cancer (18), we rated complete response (cr), pr, and sd as local tumor control. |
| PubMedID- 23729697 | (90)y radioembolization (selective internal radiation therapy [sirt]) is a valuable therapeutic option for unresectable hepatic metastases arising from primary colorectal cancer. |
| PubMedID- 26452624 | The efficacy of hepatic arterial infusion was observed in unresectable colorectal cancer patients with prognosis-determining hepatic metastases that were resistant to molecular-targeted agents and the folfox and folfiri regimens. |
| PubMedID- 20034757 | Evidence for a synchronous operative approach in the treatment of colorectal cancer with hepatic metastases: a case matched study. |
| PubMedID- 21166003 | hepatic metastases are common with colorectal cancer. |
| PubMedID- 22818215 | A 38 year self employed man has colorectal cancer with recently resected hepatic metastases. |
| PubMedID- 23047645 | In a prospective observation study, blood samples were taken from 49 consecutive colorectal cancer patients with extensive hepatic metastases before, 24 and 48 hr after re. |
Page: 1